Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation
Takeshi Tamura, … , Tomohide Tatsumi, Tetsuo Takehara
Takeshi Tamura, … , Tomohide Tatsumi, Tetsuo Takehara
Published May 25, 2021
Citation Information: J Clin Invest. 2021;131(13):e143414. https://doi.org/10.1172/JCI143414.
View: Text | PDF
Research Article Gastroenterology

Dysregulation of PI3K and Hippo signaling pathways synergistically induces chronic pancreatitis via CTGF upregulation

  • Text
  • PDF
Abstract

The role of PI3K and Hippo signaling in chronic pancreatitis (CP) pathogenesis is unclear. Therefore, we assessed the involvement of these pathways in CP by examining the PI3K and Hippo signaling components PTEN and SAV1, respectively. We observed significant decreases in pancreatic PTEN and SAV1 levels in 2 murine CP models: repeated cerulein injection and pancreatic ductal ligation. Additionally, pancreas-specific deletion of Pten and Sav1 (DKO) induced CP in mice. Pancreatic connective tissue growth factor (CTGF) was markedly upregulated in both CP models and DKO mice, and pancreatic CCAAT/enhancer-binding protein-α (CEBPA) expression was downregulated in the CP models. Interestingly, in pancreatic acinar cells (PACs), CEBPA knockdown reduced PTEN and SAV1 and increased CTGF levels in vitro. Furthermore, CEBPA knockdown in PACs induced acinar-to-ductal metaplasia and activation of cocultured macrophages and pancreatic stellate cells. These results were mitigated by CTGF inhibition. CP in DKO mice was also ameliorated by Ctgf gene deletion, and cerulein-induced CP was alleviated by antibody-mediated CTGF neutralization. Finally, we observed significantly decreased PTEN, SAV1, and CEBPA and increased CTGF levels in human CP tissues compared with nonpancreatitis tissues. Taken together, our results indicate that dysregulation of PI3K and Hippo signaling induces CP via CTGF upregulation.

Authors

Takeshi Tamura, Takahiro Kodama, Katsuhiko Sato, Kazuhiro Murai, Teppei Yoshioka, Minoru Shigekawa, Ryoko Yamada, Hayato Hikita, Ryotaro Sakamori, Hirofumi Akita, Hidetoshi Eguchi, Randy L. Johnson, Hideki Yokoi, Masashi Mukoyama, Tomohide Tatsumi, Tetsuo Takehara

×

Figure 4

Inhibition of PTEN and SAV1 in PACs may activate surrounding macrophages and PSCs via CTGF upregulation in vitro.

Options: View larger image (or click on image) Download as PowerPoint
Inhibition of PTEN and SAV1 in PACs may activate surrounding macrophages...
(A) mRNA levels of Tnfa, Il1b, and Ccl2 in RAW 264.7 cells 2 days after coculture with 266-6 cells transfected with negative control (NC) siRNA or Cebpa siRNA (#1) (CEBPA knockdown [KD] #1). (B) mRNA levels of Tgfb1, Col1a1, and Col1a2 in PSCs isolated from mouse pancreata 2 days after coculture with 266-6 cells transfected with NC siRNA or Cebpa siRNA (#1) (CEBPA KD#1). (C) mRNA levels of Tnfa, Il1b, and Ccl2 in RAW 264.7 cells 2 days after coculture with 266-6 cells transfected with NC siRNA, Ctgf siRNA (#1) (CTGF KD#1), Cebpa siRNA (#1) (CEBPA KD#1), or both Cebpa (#1) and Ctgf (#1) siRNAs (double KD [DKD] #1). (D) mRNA levels of Tgfb1, Col1a1, and Col1a2 in PSCs isolated from mouse pancreata 2 days after coculture with 266-6 cells transfected with NC siRNA, Ctgf siRNA (#1) (CTGF KD#1), Cebpa siRNA (#1) (CEBPA KD#1), or both Cebpa (#1) and Ctgf (#1) siRNAs (DKD#1). All data are presented as the means ± SDs of results for 3 samples per group. Student’s t test was used to evaluate differences between 2 groups (A and B). One-way ANOVA with Tukey’s post hoc test was used to compare differences among 4 groups (C and D). *P < 0.05 and **P < 0.005.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts